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Abstract 
Five different Quorum Sensing Peptides (QSP) were iodinated using different iodination 
techniques. These iodinated peptides were analyzed using a C18 reversed phase HPLC 
system, applying a linear gradient of water and acetonitrile containing 0.1% (m/V) formic 
acid as mobile phase. Electrospray ionization (ESI) ion trap mass spectrometry was used for 
the identification of the modified peptides, while semi-quantification was performed using 
total ion current (TIC) spectra. Non-iodinated peptides and mono- and di-iodinated peptides 
(NIP, MIP and DIP respectively) were well separated and eluted in that order. Depending on 
the used iodination method, iodination yields varied from low (2%) to high (57%). 
Abbreviations 
QSP, Quorum Sensing Peptide; NIP, Non-iodinated peptide; MIP, Mono-iodinated peptide; 
DIP, Di-iodinated peptide; BH, Bolton-Hunter; CAT, Chloramine-T 
 
Keywords: Peptide iodination, LC-UV/MS, quorum sensing, Bolton-Hunter.  
 
 
1. Introduction 
Quorum sensing peptides (QSP) are auto-inducing peptides produced by Gram-positive 
bacteria and are used in bacterial communication [1]. These peptides are secreted as large pro-
peptides by ATP-binding cassette transporters, extracellularly hydrolyzed and uptaken 
through permeases directly interacting with cytoplasmic receptors such as the RNPP proteins 
and/or sensed by membrane located receptors. Binding of the QSP to its membrane receptor 
causes auto-phosphorylation on a histidine residue and subsequent transfer of a phosphoryl 
group to a response regulator in the cytoplasm. Following phosphorylation, this response 
regulator will activate or deactivate transcription of target genes [2, 3]. Recently, it has been 
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demonstrated that some of these QSP are also able to influence human host cells, promoting 
invasion and angiogenesis of breast and colon cancer cells, thereby potentially stimulating 
tumor metastasis [4, 5]. Radiolabeling of QSP is a convenient way to study in vitro ligand 
interactions as well as in vivo pharmacokinetics. Iodination of QSP with 
125
I has already been 
performed to investigate the blood-brain barrier influx properties of some selected QSP; 
however, without analytical quality information [6]. Moreover, Verbeke et al. gives an 
overview of the currently used detection methods for unmodified QSP [7], while their 
chromatographic analysis is detailed by Debunne et al. [8]. 
Radio-iodination (i.e. incorporation of radioactive iodine such as 
123
I, 
125
I or 
131
I) is a 
technique commonly used for radioligand investigations, medical imaging and therapy [9, 
10]. Several direct and indirect iodination methods for peptides currently exist. Direct 
labelling is based on the iodination of tyrosine and histidine residues using Chloramine-T 
(CAT) [11], lactoperoxidase [12] and the Iodo-Gen
®
 method [13]. Indirect labelling is 
performed by conjugation of a small radio-iodinated molecule such as the Bolton-Hunter 
reagent (N-hydroxysuccinimide ester of 3-(4-hydroxyphenyl)propionic acid) [14]. This 
method can be used in case of absence of tyrosine and histidine residues [15]. Iodination with 
125
I is the method of choice if peptides are to be radiolabeled due to the high specific 
radioactivity and ease-of-use in counting gamma-radiation. Moreover, non-radioactive 
iodination is also used in the elucidation of structures of peptides and related products like 
foldamers [16]. While iodination is generally considered a minimal structural modification of 
the peptide, it may well induce functional differences [17, 18] as a consequence of the various 
noncovalent intermolecular interactions involving iodine atoms [19]. However, the iodination 
reaction can result in a mixture of peptides: unmodified as well as mono-and multiple-
iodinated species, as tyrosine and histidine amino acids each can give rise to 3- and 5-
diiodotyrosine, respectively 2- and 4-diiodohistidines [20].  
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Analytical characterization of iodinated peptides has been scarcely reported. Vergote et al. 
compared the iodination of obestatin using the lactoperoxidase, Iodo-Gen
®
 and chloramine-T 
methods [21]. A comparison of different iodination procedures using a variety of peptides has 
also been performed by this group [20]. Loot et al. reported the HPLC analysis of iodinated 
angiotensin-(1-7) using the Chloramine-T method [18]. The analysis of iodinated salmon 
calcitonin using reversed phase HPLC has been reported by Lee et al. [22]. De Blois et al. 
gives a clear overview of iodinated somatostatin analogues [23]. However, the analytical 
characterization of iodinated quorum sensing peptides (QSP) has not yet been reported. In this 
study, five QSP are iodinated using different techniques and their analytical characterization 
investigated. These five peptides are situated in three different clusters (clusters 2A, 2B and 
3A) of the quorum sensing peptide chemical space [24] and are involved in mediating cell 
death (Q19) [25], plasmid transfer (Q132, Q184) [26, 27], expressing virulence factors 
(Q164) [28] and inhibition of Rap phosphatases (Q206) [29]. Q19 and Q164 bind a membrane 
associated receptor while Q132, Q184 and Q206 are internalized and bind to a cytoplasmic 
receptor.  
2. Materials and methods 
2.1. Reagents & peptides 
Bolton-Hunter reagent (N-Succinimidyl 3-(4-hydroxyphenyl)propionate) and disodium 
hydrogen phosphate dihydrate were purchased from VWR (Oud-Heverlee, Belgium). Pre-
coated Iodo-Gen
®
 tubes were purchased from Thermo Scientific (Erembodegem, Belgium). 
ULC/MS grade acetonitrile and LC-MS grade formic acid were purchased from Biosolve 
(Valkenswaard, The Netherlands). Chloramine-T (N-Chloro-p-toluenesulfonamide sodium 
salt hydrate) and DMSO were purchased from Sigma-Aldrich (Diegem, Belgium). All other 
reagents were purchased from Merck (Darmstadt, Germany). Water (18.2 MΩ/cm) was 
purified in the lab by a Sartorius arium
®
 pro purification system (Goettingen, Germany). All 
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peptides were purchased from GL Biochem (Shanghai, China) (Table 1). The peptide 
numbering used in the Quorumpeps
®
 database is retained in this study [30]. 
Table 1: Quorum sensing peptides under investigation. 
Quorumpeps ID
1
  Sequence Molecular Weight Mr (Da)
2 
Q19 NNWNN 660.66 
Q132 LFSLVLAG 819.01 
Q164 SDLPFEH 843.89 
Q184 SIFTLVA 749.90 
Q206 SYPGWSW 881.94 
1 
Identification number in Quorumpeps database [30] 
2 
Molecular weight calculated using the abridged atomic weights [31].  
 
2.2. Peptide iodination using Bolton-Hunter 
To 10 µL of sodium iodide (4.5 mg/ml), 15 µL of Bolton-Hunter reagent (0.5 mg/ml), 15 µL 
of sodium hydroxide (0.1 M) and 15 µL of chloramine-T (4 mg/ml) were added. After 60 
seconds, 15 µL of sodiummetabisulphite (8 mg/ml) was added to stop the reaction. Finally, 50 
µL of the peptide solution (1 mM in 25 mM sodium phosphate buffer pH 7.4) was added to 
the mixture and incubated overnight at room temperature. 
 
2.3. Peptide iodination using Iodo-Gen
®
 
50 µL of sodium iodide (1.1 mM) and 15 µL of 0.1 M sodium hydroxide were added to a 
rinsed pre-coated Iodo-Gen
®
 tube. This mixture was incubated for 6 min at room temperature. 
The reaction mixture was added to 50 µL of peptide solution (1 mM in 25 mM sodium 
phosphate buffer pH 7.4) and further incubated for 6 minutes at room temperature. 
 
2.4. Peptide iodination using Chloramine-T (CAT) 
This method is based on the method described by Wynendaele et al. [6]. Briefly, to 50 µL of 
1 mM peptide solution, 20 µL of 4.5 mg/mL NaI in 100 mM sodium phosphate buffer, 30 µL 
of 4 mg/mL chloramine-T in 100 mM phosphate buffer and 17 µL of a 0.1 M sodium 
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hydroxide solution were added. After 40 seconds incubation, the reaction was stopped by 
adding 30 µL of sodiummetabisulphite solution (8 mg/mL). 
 
2.5. LC-MS instrumentation and conditions  
The HPLC–UV/MS apparatus consisted of a Spectra System SN4000 interface, a Spectra 
System SCM1000 degasser, a Spectra System P1000XR pump, a Spectra System AS3000 
auto sampler and a Finnigan LCQ Classic ion trap mass spectrometer in positive ion mode ( 
Thermo, San José, CA, USA) equipped with a Waters 2487 dual wavelength UV detector 
(Waters, Milford, MA, USA) and XCalibur 2.0 software (Thermo, San José, CA, USA) for 
data acquisition. The dwell volume of this setup was 1.7 ml. 
Different HPLC methods were optimized for the different peptides to obtain the shortest run 
times as possible. The first method used a XBridge
™
 BEH300 C18 (250 x 4.6 mm, 5 µm) 
stationary phase (Waters, Milford, MA, USA). Column temperature was maintained at 45°C. 
The mobile phase consisted of (A) 95/5% (V/V) H2O/acetonitrile supplemented with 0.1% 
(m/V) formic acid and (B) 5/95% (V/V) H2O/acetonitrile supplemented with 0.1% (m/V) 
formic acid. Elution was performed as described in Table 2 using a flow rate of 1 ml/min.   
The second and third method used a Vydac Everest C18 column (250 x 4.6 mm i.d., 5 µm) 
(Grace, Columbia, MD, USA). Column temperature was maintained at 30°C. The mobile 
phases consisted of H2O and acetonitrile supplemented with 0.1% (m/V) formic acid. Elution 
was performed as described in Table 2 using a flow rate of 1 ml/min. Detection was 
performed in all these methods using UV at 210 nm and ESI-MS set in positive mode (m/z: 
100-2000). The ESI-MS used a spray voltage of 4.5 kV and a capillary temperature of 250°C. 
N2 was used as sheath- and auxiliary gas with flow rates of respectively 80 and 20 ml/min. 
Peptide solutions resulting from the iodination were directly injected on the LC-MS apparatus 
without prior purification. 
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Table 2: Gradient program of HPLC methods. 
HPLC method Runtime (min) Gradient program 
1 45 5% (5 min)  58% ACN (30 min) 
2 45 2% (5 min)  50% ACN (30 min) 
3 30 15% (5 min)  45% ACN (20 min) 
 
3. Results and discussion 
3.1. MS Spectral data 
The experimental MS spectra obtained with the peptides and the iodinated derivatives 
correspond to their respective molecular structures (Table 3). The addition of a Bolton-Hunter 
molecule causes a m/z shift in [M + H]
+
 of +148 Da, while addition of a iodine-labeled 
Bolton-Hunter molecule causes a m/z shift of +274 Da. Using the Iodo-Gen
®
 method and 
CAT method, a shift of +126 Da is observed from non-iodinated peptide (NIP) to mono-
iodinated peptide (MIP) and a further shift of +126 Da to di-iodinated peptide (DIP). The 
chemistry of these iodination reactions is given in Fig. 1. A typical MS spectrum for the MIP 
of Q164 using the Iodo-Gen
®
 method, together with its corresponding MS² spectrum is given 
in Fig. 2. Peaks are observed at m/z values 970.10 Da and 485.73 Da, attributed to the [M + 
H]
+
 and [M + 2H]
2+
 ions respectively. MS spectra of the other peptides are given in the 
supplementary information. 
 
Table 3: Experimental MS spectral data obtained on iodinated QSP vs expected theoretical data. 
Peptide 
Experimental vs Theoretical m/z value ([M + H]
+
) 
NIP NIP-BH
1 
BH(I)
2 
BH(2I)
3 
MIP DIP 
Q19 661.26 
 
vs 661.67  
809.12
 
vs 809.82  
934.99
 
vs 935.71 
NA NA NA 
Q132 819.31 
 
vs 820.02  
989.52 
 
vs 990.15 
1115.39 
 
vs 1116.04  
NA NA NA 
Q164 844.27 
 
vs 844.90  
992.39 
 
vs 993.05  
1118.21
 
vs 1118.94 
NA NA NA 
844.29 
 
vs 844.90  
NA NA NA 
970.10
 
vs 970.79 
1095.83
 
vs 1096.68 
Q184 750.24 
 
vs 750.91  
920.43 
vs 921.04  
1046.34 
 
vs 1046.93  
1172.22
 
vs 1172.82 
NA NA 
Q206 882.27 
 
vs 882.95 
NA NA NA 
1008.17
 
vs 1008.84 
1134.01
 
vs 1134.73  
NA = Not applicable 
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1
 Conjugation of Bolton-Hunter reagent. 
2
 Conjugation of iodine labeled Bolton-Hunter reagent. 
3
 Conjugation of two iodine atoms coupled to a Bolton-Hunter reagent. 
3.2. Chromatography 
Due to the addition of Bolton-Hunter reagent and iodine molecules, lipophilicity of the 
peptides increases and an increase in retention time of these iodinated peptides is expected. 
An overview of the retention times of iodinated peptides is given in Table 4. All peptides 
could be analyzed using standard HPLC methods with acetonitrile, water and 0.1% (m/V) 
formic acid as mobile phase constituent. A relationship between the ratio of the percentage 
acetonitrile at the retention time of MIP versus NIP and DIP versus MIP and the molecular 
mass of the iodinated peptide divided by the number of charges in acidic medium has been 
observed by Vergote et al. [20]. An example of the UV chromatogram together with a total 
ion current (TIC) chromatogram of iodinated Q164 using the Iodo-Gen
®
 method is given in 
Fig. 3. Chromatograms of the other peptides are given in the supplementary information. 
Table 4: LC data on iodinated QSP. 
Peptide 
HPLC 
method 
Iodination 
method 
Retention time (min) 
NIP NIP-BH BH(I) BH(2I) MIP DIP 
Q19 2 Bolton-Hunter 11.05 17.74 20.73 NA NA NA 
Q132 1 Bolton-Hunter 24.94 32.60 34.82 NA NA NA 
Q164 1 Bolton-Hunter 17.87 21.88 24.45 NA NA NA 
1 Iodo-Gen
®
 17.93 NA NA NA 18.91 22.37 
Q184 1 Bolton-Hunter 24.27 29.52 31.96 34.28 NA NA 
Q206 3 CAT 15.26 NA NA NA 16.84 17.78 
NA = Not applicable 
3.3. Iodination yields 
Due to the lack of tyrosine and histidine residues, the peptides Q19, Q132 and Q184 were 
iodinated using the Bolton-Hunter method [14]. Q164 and Q206 contain a histidine or 
tyrosine residue and were iodinated using a direct method. The iodination yields are given in 
Table 5. Yields are calculated by comparing the peak area of the iodinated peptide to the total 
peak area of the peptides in the total ion current (TIC) spectrum. Iodination of Q19 using 
Bolton-Hunter resulted in a iodination yield of around 2.4%. For Q132, a low iodination yield 
of around 6% is obtained. For Q164, two iodination methods could be used. Using the Iodo-
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Gen
®
 method, a iodination yield of ±20% could be obtained compared to only ±2% using the 
Bolton-Hunter method. For Q184 a total iodination yield of around 5% is obtained. The 
Chloramine-T method for Q206 resulted in a high iodination yield of ±57%. These iodination 
yields using Bolton-Hunter are rather low as literature shows that yields up to 40% can be 
achieved using Bolton-Hunter [32]. 
Table 5: Iodination yields of quorum sensing peptides. 
Peptide 
Amount 
(nmol) 
Iodination 
method 
Area % (TIC) 
NIP NIP-BH BH(I) BH(2I) MIP DIP 
Q19 5 Bolton-Hunter 75.9 21.7 2.4 NA NA NA 
Q132 5 Bolton-Hunter 86.9 7.3 5.8 NA NA NA 
Q164 5 Bolton-Hunter 82.6 15.6 1.8 NA NA NA 
Iodo-Gen
®
 80.7 NA NA NA 9.6 9.6 
Q184 5 Bolton-Hunter 95.0 0.2 2.2 2.6 NA NA 
Q206 5 CAT 42.6 NA NA NA 34.7 22.7 
NA = Not applicable 
In most pharmacokinetic studies using iodine labelling, no isolation of mono-iodinated 
peptides is performed. A mixture of non-iodinated, mono-iodinated and multiple-iodinated 
peptides is used [6, 33, 34]. When saturable transport mechanisms are used, the presence of 
non-labeled peptide will underestimate the transport properties of the peptide as less radio-
labeled peptide is transported due to competition of the NIP transport [35]. The observed 
effect can also be the result of multiple-iodinated peptides. These peptides underwent the 
biggest changes as iodination with multiple 
125
I atoms increases the peptide size and 
hydrophobicity and can also affect the secondary structure of the peptide, thereby changing 
also the physico-chemical as well as the pharmacokinetic and pharmacodynamic properties 
[36, 37]. Furthermore, radiolabeling of peptides can influence the biological properties such 
as receptor affinity, bio-distribution, internalization and cell dissociation [15]. For most 
biomedical and pharmaceutical applications, single iodinated peptides are desirable as they 
are expected to functionally behave closest to the unmodified peptide compared to the 
multiple-iodinated species. Therefore, it is advantageous to isolate the mono-iodinated peptide 
for biomedical studies of these quorum sensing peptides.  
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4. Conclusions 
Iodinated quorum sensing peptides were separated by HPLC using a C18 column with water-
acetonitrile mobile phase gradients and 0.1% (m/V) formic acid. Iodinated peptides were 
identified using mass spectrometry and quantitatively estimated using normalization of the 
peak areas from the total ion current chromatograms. Iodination yields were variable, ranging 
from 2% to 57% depending on the used iodination method.  
 
Conflict of interest 
The authors have no conflict of interest to declare. 
 
Acknowledgements 
The authors thank the ‘Research Foundation – Flanders (FWO)’ (grant number 1S21017N to 
Nathan Debunne) and the ‘Institute for the Promotion of Innovation through Science and 
Technology in Flanders (IWT-Vlaanderen)’ (grant number 131356 to Frederick Verbeke). 
 
 
References 
[1] M. H. Sturme, M. Kleerebezem, J. Nakayama, et al. Cell to cell communication by 
autoinducing peptides in gram-positive bacteria. Antonie Van Leeuwenhoek. 2002;81(1-4):233-43. 
[2] M. B. Miller, B. L. Bassler. Quorum sensing in bacteria. Annu Rev Microbiol. 2001;55:165-99. 
[3] J. Rocha-Estrada, A. E. Aceves-Diez, G. Guarneros, et al. The RNPP family of quorum-sensing 
proteins in Gram-positive bacteria. Appl. Microbiol. Biotechnol. 2010;87(3):913-23. 
[4] B. De Spiegeleer, F. Verbeke, M. D'Hondt, et al. The quorum sensing peptides PhrG, CSP and 
EDF promote angiogenesis and invasion of breast cancer cells in vitro. PLoS One. 
2015;10(3):e0119471. 
[5] E. Wynendaele, F. Verbeke, M. D'Hondt, et al. Crosstalk between the microbiome and cancer 
cells by quorum sensing peptides. Peptides. 2015;64:40-8. 
[6] E. Wynendaele, F. Verbeke, S. Stalmans, et al. Quorum Sensing Peptides Selectively Penetrate 
the Blood-Brain Barrier. PLoS One. 2015;10(11):e0142071. 
[7] F. Verbeke, S. De Craemer, N. Debunne, et al. Peptides as Quorum Sensing Molecules: 
Measurement Techniques and Obtained Levels In vitro and In vivo. Front. Neurosci. 2017;11:183. 
Page 11 of 14 
 
[8] N. Debunne, F. Verbeke, Y. Janssens, et al. Chromatography of quorum sensing peptides, an 
important functional class of the bacterial peptidome. Chromatographia 2017;Manuscript submitted. 
[9] L. Chen, X. Zhong, X. Yi, et al. Radionuclide (131)I labeled reduced graphene oxide for nuclear 
imaging guided combined radio- and photothermal therapy of cancer. Biomaterials. 2015;66:21-8. 
[10] L. Li, C. L. Zhang, L. Kang, et al. Enhanced EJ Cell Killing of (125)I Radiation by Combining with 
Cytosine Deaminase Gene Therapy Regulated by Synthetic Radio-Responsive Promoter. Cancer 
Biother. Radiopharm. 2015;30(8):342-8. 
[11] R. Hunter. Standardization of the chloramine-T method of protein iodination. Proc. Soc. Exp. 
Biol. Med. 1970;133(3):989-92. 
[12] J. J. Marchalonis. An enzymic method for the trace iodination of immunoglobulins and other 
proteins. Biochem. J. 1969;113(2):299-305. 
[13] J. M. Conlon. The use of IODO-GEN for preparing 125I-labeled peptides and their purification 
by reversed-phase high performance liquid chromatography. Methods Mol. Biol. 1997;73:231-7. 
[14] A. E. Bolton, W. M. Hunter. The labelling of proteins to high specific radioactivities by 
conjugation to a 125I-containing acylating agent. Biochem. J. 1973;133(3):529-39. 
[15] E. Wynendaele, N. Bracke, S. Stalmans, et al. Development of peptide and protein based 
radiopharmaceuticals. Curr. Pharm. Des. 2014;20(14):2250-67. 
[16] G. W. Collie, K. Pulka-Ziach, G. Guichard. In situ iodination and X-ray crystal structure of a 
foldamer helix bundle. Chem. Commun. (Camb). 2016;52(6):1202-5. 
[17] A. Bertolani, L. Pirrie, L. Stefan, et al. Supramolecular amplification of amyloid self-assembly 
by iodination. Nat. Commun. 2015;6:7574. 
[18] A. E. Loot, A. van Buiten, A. J. Roks, et al. The suitability of iodinated Angiotensin-(1-7) 
peptides as pharmacological tools. J. Pharmacol. Toxicol. Methods. 2005;51(1):51-5. 
[19] R. Glaser, R. Murphy. What's in a name? Noncovalent Ar-Cl (H-Ar')n interactions and 
terminology based on structure and nature of the bonding. CrystEngComm. 2006;8:948-51. 
[20] V. Vergote, S. Bode, K. Peremans, et al. Analysis of iodinated peptides by LC-DAD/ESI ion trap 
mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007;850(1-2):213-20. 
[21] V. Vergote, B. Baert, E. Vandermeulen, et al. LC-UV/MS characterization and DOE 
optimization of the iodinated peptide obestatin. J. Pharm. Biomed. Anal. 2008;46(1):127-36. 
[22] K. C. Lee, T. S. Kang, B. H. Woo, et al. Reversed-phase high-performance liquid 
chromatography of radioiodinated salmon calcitonins. J. Chromatogr. B Biomed. Sci. Appl. 
1997;694(1):31-7. 
[23] E. de Blois, H. S. Chan, W. A. Breeman. Iodination and stability of somatostatin analogues: 
comparison of iodination techniques. A practical overview. Curr. Top. Med. Chem. 2012;12(23):2668-
76. 
[24] E. Wynendaele, B. Gevaert, S. Stalmans, et al. Exploring the chemical space of quorum 
sensing peptides. Biopolymers. 2015;104(5):544-51. 
[25] I. Kolodkin-Gal, R. Hazan, A. Gaathon, et al. A linear pentapeptide is a quorum-sensing factor 
required for mazEF-mediated cell death in Escherichia coli. Science. 2007;318(5850):652-5. 
[26] J. Nakayama, Y. Ono, A. Suzuki. Isolation and structure of the sex pheromone inhibitor, 
iAM373, of Enterococcus faecalis. Biosci. Biotechnol. Biochem. 1995;59(7):1358-9. 
[27] R. Wirth. The sex pheromone system of Enterococcus faecalis. More than just a plasmid-
collection mechanism? Eur. J. Biochem. 1994;222(2):235-46. 
[28] L. Bouillaut, S. Perchat, S. Arold, et al. Molecular basis for group-specific activation of the 
virulence regulator PlcR by PapR heptapeptides. Nucleic Acids Res. 2008;36(11):3791-801. 
[29] M. Perego, J. A. Brannigan. Pentapeptide regulation of aspartyl-phosphate phosphatases. 
Peptides. 2001;22(10):1541-7. 
[30] E. Wynendaele, A. Bronselaer, J. Nielandt, et al. Quorumpeps database: chemical space, 
microbial origin and functionality of quorum sensing peptides. Nucleic Acids Res. 2013;41(Database 
issue):D655-9. 
[31] B. De Spiegeleer, M. D'Hondt. Molecular weights under discussion? Pharmeuropa. 
2012;24(April). 
Page 12 of 14 
 
[32] J. Russell, J. A. O'Donoghue, R. Finn, et al. Iodination of annexin V for imaging apoptosis. J. 
Nucl. Med. 2002;43(5):671-7. 
[33] B. Gevaert, E. Wynendaele, S. Stalmans, et al. Blood-brain barrier transport kinetics of the 
neuromedin peptides NMU, NMN, NMB and NT. Neuropharmacology. 2016;107:460-70. 
[34] S. Stalmans, N. Bracke, E. Wynendaele, et al. Cell-Penetrating Peptides Selectively Cross the 
Blood-Brain Barrier In Vivo. PLoS One. 2015;10(10):e0139652. 
[35] A. J. Kastin, V. Akerstrom, W. Pan. Validity of multiple-time regression analysis in 
measurement of tritiated and iodinated leptin crossing the blood-brain barrier: meaningful controls. 
Peptides. 2001;22(12):2127-36. 
[36] Y. Efimova, B. Wierczinski, S. Haemers, et al. Changes in the secondary structure of proteins 
with 125I: CD spectroscopy and enzymatic activity studies. J. Radioanal. Nucl. Chem. 2005;264:91-6. 
[37] R. J. Bauer, S. D. Leigh, C. A. Birr, et al. Alteration of the pharmacokinetics of small proteins by 
iodination. Biopharm. Drug Dispos. 1996;17(9):761-74. 
 
 
 
 
Figure captions 
Fig 1. (A) Iodination using the Bolton-Hunter method. The Bolton-Hunter reagent is 
iodinated using NaI, the iodinated Bolton-Hunter molecule reacts with the amino-terminus of 
the peptides. (B) Iodination using the Iodogen
®
- or Chloramine-T method. Peptides are 
iodinated on the Tyrosine (Q206) and or Histidine (Q164) residues. 
Fig 2. (A) LC-MS spectrum of mono-iodinated Q164 using the Iodogen
®
 method, (B) MS² 
spectrum of mono-iodinated Q164 with [M + H]
+
 as parent-ion.  
Fig 3. (A) TIC chromatogram of Q164 using the Iodogen
®
 method (B) UV chromatogram of 
Q164. Peaks at 17.93, 18.91 and 22.37 minutes are identified as NIP, MIP and DIP 
respectively. 
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